ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • Search
  • My Favorites
    • View and print all favorites
    • Clear all favorites

Abstract Number: 686

Endothelial Dysfunction in Systemic Lupus Erythematosus Patients without Cardiovascular events and Risk Factors: Correlation with Microvascular Alterations and angiogenic t Cells

Ilaria Cavazzana1, Mara Taraborelli2, Silvia Piantoni3, Ivano Bonadei4, Edoardo Sciatti5, Micaela Fredi6, Marco Metra4, Angela Tincani7, Franco Franceschini1 and Enrico Vizzardi4, 1Rheumatology and Clinical Immunology, Spedali Civili of Brescia, Brescia, Italy, 2Internal Medicine; Ospedale Mellini, Chiari (Brescia), Italy, 3Rheumatology and Clinical Immunology Unit, Spedali Civili, University of Brescia, Brescia, Italy, 4Cardiology Unit, Spedali Civili, University of Brescia, Brescia, Italy, 5Cardiology Unit, Spedali Civili, University of Brescia, Brsecia, Italy, 6Department of Rheumatology and Clinical Immunology, Rheumatology and Clinical Immunology, Rheumatology and Clinical Immunology, Spedali Civili of Brescia, Brescia, Italy, 7Rheumatology and Clinical Immunology, Spedali Civili and University of Brescia, Brescia, Italy

Meeting: ACR/ARHP Annual Meeting 2017

Date of first publication: September 18, 2017

Keywords: Capillaroscopy, Cardiovascular disease, endothelial cells, lymphocytes and systemic lupus erythematosus (SLE)

  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print
Session Information

Date: Sunday, November 5, 2017

Title: Systemic Lupus Erythematosus – Clinical Aspects and Treatment Poster I: Biomarkers and Outcomes

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: early identification of subclinical cardiovascular disease (CVD) in systemic lupus erythematosus (SLE) patients is mandatory to reduce morbidity and mortality. Endothelial dysfunction (ED) is one of the first steps of the process leading to atherosclerosis and has been associated with further CVD development. Aim of the study was to assess the prevalence of ED by a non invasive procedure in SLE patients with early disease without CVD and risk factors, and correlate ED with nailfold capillary morphology and angiogenic T (angT) cells. AngT cells are a T cell subpopulation, involved in repair mechanisms of the endothelium, cooperating with endothelial progenitors cells.

Methods: all the consecutive SLE patients, according to SLICC Classification Criteria, with a disease duration less than 5 years, evalued from december 2014 to march 2016 were proposed to participate to the study. Exclusion criteria were represented by history of CVD, diabetes, chronic renal disease (creatinine clearance<60 ml/min), not controlled systemic arterial hypertension, current or past smoking (in the last 3 years), hypercholesterolemia (total cholesterol>240 mg/dl), obesity (body mass index > or =30), statin or beta-blocker use. Each patient underwent a clinical and serological evaluation, a transthoracic doppler echocardiogram, endothelial function study by endoPAT technique, nailfold videocapillaroscopy (NVC) and T cell subpopulation study. Characteristics of patients with ED (ED+), defined as reactive hyperemic index < or= 2, were compared to those of patients without ED (ED-) and normal controls, matched for age, sex and CV exclusion criteria, by Fisher, T student or Mann-Whitney tests as appropriate.

Results: Among 46 screened SLE patients, 20 patients were enrolled (100% female, 80% caucasian) with a median disease duration of 14 months (0-68), a mean age of 42 years (±15), and a mean age at diagnosis of 40 years (±16). Arthritis, cutaneous and hematological features were found in 70%, 55% and 65% of cases, respectively. ANA, antidsDNA and anti-ENA were found in 100%, 50% and 50% of cases. Anti-cardiolipin and antibeta2glycoprotien I antibodies in 20% and 10%. ED was found in 8 patients (40%). ED didn’t correlate with any demographic-clinical-serological-echocardiographic features. A significantly higher prevalence of ED (p:0.003), vascular stiffness (p:0.02), left ventricular concentric remodelling (p:0.003), grade I diastolic dysfunction (p:0.04) were found in SLE patients compared to controls.

ED+ patients more frequently showed minor NVC abnormalities (i.e. tortuous,/crossed/enlarged) (p: 0,007), lower capillary number/mm (p: 0,01) and wider intercapillary distance (p: 0,06) compared to controls. AngT cells were significantly reduced in SLE patients compared to controls (p: 0,045), but they were increased in ED+ SLE compared to ED- (p: 0,04).

Conclusion: A significant proportion of SLE patients showed signs of ED despite a recent disease and the absence of cardiovascular risk factors. ED correlates with microvascular alterations by videocapillaroscopy and increased ang T cells, as marker of endothelium repair.


Disclosure: I. Cavazzana, None; M. Taraborelli, None; S. Piantoni, None; I. Bonadei, None; E. Sciatti, None; M. Fredi, None; M. Metra, None; A. Tincani, None; F. Franceschini, None; E. Vizzardi, None.

To cite this abstract in AMA style:

Cavazzana I, Taraborelli M, Piantoni S, Bonadei I, Sciatti E, Fredi M, Metra M, Tincani A, Franceschini F, Vizzardi E. Endothelial Dysfunction in Systemic Lupus Erythematosus Patients without Cardiovascular events and Risk Factors: Correlation with Microvascular Alterations and angiogenic t Cells [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/endothelial-dysfunction-in-systemic-lupus-erythematosus-patients-without-cardiovascular-events-and-risk-factors-correlation-with-microvascular-alterations-and-angiogenic-t-cells/. Accessed .
  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

« Back to ACR/ARHP Annual Meeting 2017

ACR Meeting Abstracts - https://acrabstracts.org/abstract/endothelial-dysfunction-in-systemic-lupus-erythematosus-patients-without-cardiovascular-events-and-risk-factors-correlation-with-microvascular-alterations-and-angiogenic-t-cells/

Advanced Search

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology